IP Library Granted Patent US 11,692,184
Granted Patent B2
US 11,692,184 · App. 16/604,946 · Granted Jul 4, 2023

Thermostable RNA-guided endonucleases and methods of use thereof

Inventors: Nikos C. Kyrpides (Berkeley, CA); Jennifer A. Doudna (Berkeley, CA); Lucas Benjamin Harrington (Berkeley, CA); David Paez-Espino (Walnut Creek, CA)
Assignee: The regents of the university of california
C12N9/22C12N15/113C07K2319/00C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,692,184
App. No.
16/604,946
Granted
Jul 4, 2023
Kind
B2
Abstract

The present disclosure provides RNA-guided endonucleases, nucleic acids encoding same, and compositions comprising same. The present disclosure provides ribonucleoprotein complexes comprising: an RNA-guided endonuclease of the present disclosure; and a guide RNA. The present disclosure provides methods of modifying a target nucleic acid, using an RNA-guided endonuclease of the present disclosure and a guide RNA.

Claims (34)

1. An RNA-guided endonuclease that comprises:

a) an amino acid sequence having at least 95% amino acid sequence identity to amino acids 1-994 of the amino acid sequence set forth in SEQ ID NO: 1; and

b) a heterologous protospacer adjacent motif (PAM) interacting (PI) domain comprising an amino acid sequence having at least 95% amino acid sequence identity to the following amino acid sequence: IIKTAGGEEIKIKDLFAYYKTIHSGTAGLELVSHDCSFSLSGVGSRTLKRFEKYQVDVLGNIYKVRGEKRVGLASSAHSKTGETIRPLQSTRD (SEQ ID NO: 4), wherein the PI domain is heterologous to the amino acid sequence of part a).

2. The RNA-guided endonuclease of claim 1 , wherein the RNA-guided endonuclease is enzymatically active in a temperature range of from 15° C. to 75° C.

3. The RNA-guided endonuclease of claim 1 , wherein the RNA-guided endonuclease binds to a target nucleic acid comprising a PAM comprising a GMAA sequence, wherein M is A or C.

4. The RNA-guided endonuclease of claim 1 , wherein the heterologous PI domain comprises an amino acid sequence having at least 99% amino acid sequence identity to the following amino acid sequence:

(SEQ ID NO: 4)

IIKTAGGEEIKIKDLFAYYKTIHSGTAGLELVSHDCSFSLSGVGSRTLKRF

EKYQVDVLGNIYKVRGEKRVGLASSAHSKTGETIRPLQSTRD.

5. The RNA-guided endonuclease of claim 1 , wherein the heterologous PI domain comprises an amino acid sequence having less than 83% amino acid sequence identity to the following amino acid sequence:

(SEQ ID NO: 5)

TVKTAAGEEINVKDVFVYYKTIDSANGGLELISHDHRFSLRGVGSRTLKRF

EKYQVDVLGNIYKVRGEKRVGLASSAHSKPGKTIRPLQSTRD.

6. The RNA-guided endonuclease of claim 1 , wherein the RNA-guided endonuclease has a length of from 1050 amino acids to 1120 amino acids.

7. The RNA-guided endonuclease of claim 1 , wherein the RNA-guided endonuclease has a length of from 1080 amino acids to 1095 amino acids.

8. The RNA-guided endonuclease of claim 1 , wherein the RNA-guided endonuclease comprises an amino acid sequence having at least 99% amino acid sequence identity to amino acids 1-994 of the amino acid sequence set forth in SEQ ID NO: 1.

9. The RNA-guided endonuclease of claim 1 , wherein the RNA-guided endonuclease comprises: a) a substitution of amino acid Asp-8; b) a substitution of amino acid His-582; or c) substitution of both Asp-8 and His-582, based on the amino acid numbering of the amino acid sequence of SEQ ID NO:1.

10. A fusion polypeptide comprising:

a) an RNA-guided endonuclease that comprises:

i) an amino acid sequence having at least 95% amino acid sequence identity to amino acids 1-994 of the amino acid sequence set forth in SEQ ID NO: 1; and

ii) a heterologous protospacer adjacent motif (PAM) interacting (PI) domain comprising an amino acid sequence having at least 95% amino acid sequence identity to the following amino acid sequence: IIKTAGGEEIKIKDLFAYYKTIHSGTAGLELVSHDCSFSLSGVGSRTLKRFEKYQVDVLGNIYKVRGEKRVGLASSAHSKTGETIRPLQSTRD (SEQ ID NO: 4), wherein the PI domain is heterologous to the amino acid sequence of part i); and

b) a heterologous fusion partner polypeptide.

11. A cell comprising the RNA-guided endonuclease of claim 1 .

12. A ribonucleoprotein (RNP) complex comprising:

a1) the RNA-guided endonuclease of claim 1 ; and

b1) a guide RNA comprising:

i) a DNA-targeting segment comprising a nucleotide sequence that is complementary to a target nucleotide sequence in a target nucleic acid; and

ii) a protein-binding segment that binds to and activates the thermostable RNA-guided endonuclease, wherein the protein-binding segment comprises a duplex-forming linker segment and a tracrRNA.

13. A method of modifying a target DNA, the method comprising contacting the target DNA with the RNP complex of claim 12 .

14. The RNA-guided endonuclease of claim 1 , wherein the RNA-guided endonuclease comprises:

a) an amino acid sequence having amino acids 1-994 of the sequence set forth in SEQ ID NO: 1; and

b) a heterologous PI domain comprising the amino acid sequence of SEQ ID NO: 4.

15. The fusion polypeptide of claim 10 , wherein the RNA-guided endonuclease comprises an amino acid sequence having at least 99% amino acid sequence identity to amino acids 1-994 of the amino acid sequence set forth in SEQ ID NO: 1.

16. The fusion polypeptide of claim 10 , wherein the heterologous PI domain comprises an amino acid sequence having at least 99% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO: 4.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 5, 2025
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 070112/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2022
From: DOUDNA, JENNIFER A.; HARRINGTON, LUCAS BENJAMIN; KYRPIDES, NIKOS C.; PAEZ-ESPINO, DAVID
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 062106/0750 →
Continuity (2)
Provisional Application 62507123 · May 16, 2017
Related Publication 20200392472A1 · Dec 17, 2020
Cited By (1)
US 12,281,338